T. Arami

Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study

Y. Ohe, R. Uozumi, K. Fukunaga, 2021, Frontiers in Oncology.

Peripheral blood biomarkers predict immune-related adverse events in non-small cell lung cancer patients treated with pembrolizumab: a multicenter retrospective study

Y. Ohe, R. Uozumi, K. Fukunaga, 2021, Journal of Cancer.